{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:53:49Z","timestamp":1794887629981,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Human granulocytic anaplasmosis (HGA) is a systemic inflammatory response caused by the rickettsial bacterium<jats:italic>Anaplasma phagocytophilum<\/jats:italic>. Rhabdomyolysis and acute kidney injury (AKI) are rare complications of HGA. Here, we report a case of HGA concurrent with rhabdomyolysis and AKI in an elderly patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>An 84-year old woman with a medical history of hypertension was hospitalised after two days of fever, dizziness, whole body pain, and general weakness. Laboratory investigations showed severe thrombocytopenia, leukopenia, impaired renal function, and elevated cardiac enzyme and myoglobin levels. On the day after admission, peripheral blood smear revealed morula inclusions in neutrophils, a suggestive finding of HGA. Real-time polymerase chain reaction (PCR) results indicated the presence of<jats:italic>A. phagocytophilum<\/jats:italic>. Antibiotics were de-escalated to doxycycline monotherapy. After 10\u00a0days of antibiotic treatment, laboratory tests showed complete recovery from HGA complicated with rhabdomyolysis and AKI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HGA can lead to serious complications in patients with associated risk factors. Therefore, in patients with HGA accompanied by rhabdomyolysis, management with antibiotics and hydration should be initiated immediately, and not delayed until diagnostic confirmation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-021-06869-z","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T12:03:08Z","timestamp":1637841788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human granulocytic anaplasmosis combined with rhabdomyolysis: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-994X","authenticated-orcid":false,"given":"Jeong Min","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-7195","authenticated-orcid":false,"given":"Jeonghyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-0922","authenticated-orcid":false,"given":"Dong-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-8045","authenticated-orcid":false,"given":"Yee Gyung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-8952","authenticated-orcid":false,"given":"Chong Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-6905","authenticated-orcid":false,"given":"Je Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"issue":"2","key":"6869_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.idc.2015.02.007","volume":"29","author":"JS Bakken","year":"2015","unstructured":"Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am. 2015;29(2):341\u201355.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"6869_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3201\/eid2010.131680","volume":"20","author":"KH Kim","year":"2014","unstructured":"Kim KH, Yi J, Oh WS, Kim NH, Choi SJ, Choe PG, et al. Human granulocytic anaplasmosis, South Korea, 2013. Emerg Infect Dis. 2014;20(10):1708\u201311.","journal-title":"Emerg Infect Dis"},{"key":"6869_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1196\/annals.1374.042","volume":"1078","author":"JS Bakken","year":"2006","unstructured":"Bakken JS, Dumler JS. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci. 2006;1078:236\u201347.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"6869_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jama.1994.03520030054028","volume":"272","author":"JS Bakken","year":"1994","unstructured":"Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 1994;272(3):212\u20138.","journal-title":"JAMA"},{"issue":"2","key":"6869_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","volume":"65","author":"HM Biggs","year":"2016","unstructured":"Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis\u2014United States. MMWR Recomm Rep. 2016;65(2):1\u201344.","journal-title":"MMWR Recomm Rep"},{"key":"6869_CR6","unstructured":"Prevention. CDC. Anaplasmosis. Epidemiology and Statistics. 2019. https:\/\/www.cdc.gov\/anaplasmosis\/stats\/index.html. Accessed 6 Aug 2021."},{"issue":"4","key":"6869_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4269\/ajtmh.16-0309","volume":"96","author":"J Yi","year":"2017","unstructured":"Yi J, Kim KH, Ko MK, Lee EY, Choi SJ, Oh MD. Human granulocytic anaplasmosis as a cause of febrile illness in Korea since at least 2006. Am J Trop Med Hyg. 2017;96(4):777\u201382.","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"6869_CR8","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1086\/518146","volume":"45","author":"JS Dumler","year":"2007","unstructured":"Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007;45(Suppl 1):S45-51.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"6869_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/313948","volume":"31","author":"JS Bakken","year":"2000","unstructured":"Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000;31(2):554\u201360.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6869_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4269\/ajtmh.2011.10-0613","volume":"85","author":"FS Dahlgren","year":"2011","unstructured":"Dahlgren FS, Mandel EJ, Krebs JW, Massung RF, McQuiston JH. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000\u20132007. Am J Trop Med Hyg. 2011;85(1):124\u201331.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"6869_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0025-6196(11)61006-9","volume":"82","author":"F Boateng","year":"2007","unstructured":"Boateng F, Ohene-Adjei R, Amoateng-Adjepong Y. Rhabdomyolysis and acute renal failure associated with human granulocytic anaplasmosis. Mayo Clin Proc. 2007;82(2):250.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"6869_CR12","first-page":"82","volume":"110","author":"SR Talsness","year":"2011","unstructured":"Talsness SR, Shukla SK, Mazza JJ, Yale SH. Rhabdomyolysis-induced acute kidney injury secondary to Anaplasma phagocytophilum and concomitant statin use. WMJ. 2011;110(2):82\u20134.","journal-title":"WMJ"},{"issue":"13","key":"6869_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMcpc059004","volume":"352","author":"HM Heller","year":"2005","unstructured":"Heller HM, Telford SR, Branda JA. Case records of the Massachusetts General Hospital. Case 10\u20132005. A 73-year-old man with weakness and pain in the legs. N Engl J Med. 2005;352(13):1358\u201364.","journal-title":"N Engl J Med"},{"key":"6869_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.03.066","author":"J Jawanda","year":"2020","unstructured":"Jawanda J. Rare case of severe rhabdomyolysis secondary to human granulocytic anaplasmosis. Am J Emerg Med. 2020. https:\/\/doi.org\/10.1016\/j.ajem.2020.03.066.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"6869_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.medcli.2011.05.021","volume":"139","author":"J Herr\u00e1ez Garc\u00eda","year":"2012","unstructured":"Herr\u00e1ez Garc\u00eda J, Torracchi Carrasco AM, Antol\u00ed-Royo AC, de la Fuente Blanco R, Santos Jim\u00e9nez MT. Rhabdomyolysis. A descriptive study of 449 patients. Med Clin. 2012;139(6):238\u201342.","journal-title":"Med Clin"},{"issue":"1","key":"6869_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","volume":"20","author":"LO Chavez","year":"2016","unstructured":"Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Critical care (London, England). 2016;20(1):135.","journal-title":"Critical care (London, England)"},{"issue":"8","key":"6869_CR17","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1128\/IAI.71.8.4586-4594.2003","volume":"71","author":"KS Choi","year":"2003","unstructured":"Choi KS, Garyu J, Park J, Dumler JS. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun. 2003;71(8):4586\u201394.","journal-title":"Infect Immun"},{"issue":"2","key":"6869_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/518834","volume":"45","author":"JS Dumler","year":"2007","unstructured":"Dumler JS, Barat NC, Barat CE, Bakken JS. Human granulocytic anaplasmosis and macrophage activation. Clin Infect Dis. 2007;45(2):199\u2013204.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06869-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06869-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06869-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:14:36Z","timestamp":1726186476000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06869-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6869"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06869-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the IRB of Inje University (IRB number 2018-04-005). Written consent to participate in this study was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1184"}}